Eli Lilly and Company
Imidazolidine compounds

Abstract:

The present invention provides a compound of Formula (I) wherein X is selected from the group consisting of (CH.sub.2).sub.2-- and CH.sub.2--CH(CH.sub.3)--; Q is selected from the group consisting of C(CH.sub.3).sub.2 and Formula (a); or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH. ##STR00001##